Keywords: eli, lilly, bi, alter, yentreve/ariclaim, deal, usa-based

Eli Lilly and BI alter Yentreve/AriClaim deal

Article | 20 February 2006

USA-based drugmaker Eli Lilly and Germany's Boehringer Ingelheim say that they have altered contractual agreements relating to Yentreve/AriClaim (duloxetine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Lilly

Boehringer Ingelheim

Go to company listing

Related Drugs

Cymbalta

Duloxetine Hcl

Go to drug listing